157 related articles for article (PubMed ID: 21554903)
1. Treatment of spatial memory impairment in hamsters infected with West Nile virus using a humanized monoclonal antibody MGAWN1.
Smeraski CA; Siddharthan V; Morrey JD
Antiviral Res; 2011 Jul; 91(1):43-9. PubMed ID: 21554903
[TBL] [Abstract][Full Text] [Related]
2. Defining limits of treatment with humanized neutralizing monoclonal antibody for West Nile virus neurological infection in a hamster model.
Morrey JD; Siddharthan V; Olsen AL; Wang H; Julander JG; Hall JO; Li H; Nordstrom JL; Koenig S; Johnson S; Diamond MS
Antimicrob Agents Chemother; 2007 Jul; 51(7):2396-402. PubMed ID: 17452485
[TBL] [Abstract][Full Text] [Related]
3. Humanized monoclonal antibody against West Nile virus envelope protein administered after neuronal infection protects against lethal encephalitis in hamsters.
Morrey JD; Siddharthan V; Olsen AL; Roper GY; Wang H; Baldwin TJ; Koenig S; Johnson S; Nordstrom JL; Diamond MS
J Infect Dis; 2006 Nov; 194(9):1300-8. PubMed ID: 17041857
[TBL] [Abstract][Full Text] [Related]
4. Safety and pharmacokinetics of single intravenous dose of MGAWN1, a novel monoclonal antibody to West Nile virus.
Beigel JH; Nordstrom JL; Pillemer SR; Roncal C; Goldwater DR; Li H; Holland PC; Johnson S; Stein K; Koenig S
Antimicrob Agents Chemother; 2010 Jun; 54(6):2431-6. PubMed ID: 20350945
[TBL] [Abstract][Full Text] [Related]
5. West Nile virus-induced acute flaccid paralysis is prevented by monoclonal antibody treatment when administered after infection of spinal cord neurons.
Morrey JD; Siddharthan V; Wang H; Hall JO; Skirpstunas RT; Olsen AL; Nordstrom JL; Koenig S; Johnson S; Diamond MS
J Neurovirol; 2008 Apr; 14(2):152-63. PubMed ID: 18444087
[TBL] [Abstract][Full Text] [Related]
6. Modeling hamsters for evaluating West Nile virus therapies.
Morrey JD; Day CW; Julander JG; Olsen AL; Sidwell RW; Cheney CD; Blatt LM
Antiviral Res; 2004 Jul; 63(1):41-50. PubMed ID: 15196819
[TBL] [Abstract][Full Text] [Related]
7. Effect of interferon-alpha and interferon-inducers on West Nile virus in mouse and hamster animal models.
Morrey JD; Day CW; Julander JG; Blatt LM; Smee DF; Sidwell RW
Antivir Chem Chemother; 2004 Mar; 15(2):101-9. PubMed ID: 15185728
[TBL] [Abstract][Full Text] [Related]
8. An Overview of Current Approaches Toward the Treatment and Prevention of West Nile Virus Infection.
Acharya D; Bai F
Methods Mol Biol; 2016; 1435():249-91. PubMed ID: 27188563
[TBL] [Abstract][Full Text] [Related]
9. Respiratory insufficiency correlated strongly with mortality of rodents infected with West Nile virus.
Morrey JD; Siddharthan V; Wang H; Hall JO
PLoS One; 2012; 7(6):e38672. PubMed ID: 22719920
[TBL] [Abstract][Full Text] [Related]
10. Neurological suppression of diaphragm electromyographs in hamsters infected with West Nile virus.
Morrey JD; Siddharthan V; Wang H; Hall JO; Motter NE; Skinner RD; Skirpstunas RT
J Neurovirol; 2010 Jul; 16(4):318-29. PubMed ID: 20632796
[TBL] [Abstract][Full Text] [Related]
11. Autonomic deficit not the cause of death in West Nile virus neurological disease.
Wang H; Siddharthan V; Hall JO; Morrey JD
Clin Auton Res; 2014 Feb; 24(1):15-23. PubMed ID: 24158383
[TBL] [Abstract][Full Text] [Related]
12. Autonomic nervous dysfunction in hamsters infected with West Nile virus.
Wang H; Siddharthan V; Hall JO; Morrey JD
PLoS One; 2011 May; 6(5):e19575. PubMed ID: 21573009
[TBL] [Abstract][Full Text] [Related]
13. Effects of immunosuppression on West Nile virus infection in hamsters.
Mateo R; Xiao SY; Guzman H; Lei H; Da Rosa AP; Tesh RB
Am J Trop Med Hyg; 2006 Aug; 75(2):356-62. PubMed ID: 16896148
[TBL] [Abstract][Full Text] [Related]
14. West Nile virus preferentially transports along motor neuron axons after sciatic nerve injection of hamsters.
Wang H; Siddharthan V; Hall JO; Morrey JD
J Neurovirol; 2009 Jul; 15(4):293-9. PubMed ID: 19504391
[TBL] [Abstract][Full Text] [Related]
15. Persistent West Nile virus infection in the golden hamster: studies on its mechanism and possible implications for other flavivirus infections.
Tesh RB; Siirin M; Guzman H; Travassos da Rosa AP; Wu X; Duan T; Lei H; Nunes MR; Xiao SY
J Infect Dis; 2005 Jul; 192(2):287-95. PubMed ID: 15962223
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and durability of a recombinant subunit West Nile vaccine candidate in protecting hamsters from West Nile encephalitis.
Watts DM; Tesh RB; Siirin M; Rosa AT; Newman PC; Clements DE; Ogata S; Coller BA; Weeks-Levy C; Lieberman MM
Vaccine; 2007 Apr; 25(15):2913-8. PubMed ID: 17067727
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of orally administered T-705 pyrazine analog on lethal West Nile virus infection in rodents.
Morrey JD; Taro BS; Siddharthan V; Wang H; Smee DF; Christensen AJ; Furuta Y
Antiviral Res; 2008 Dec; 80(3):377-9. PubMed ID: 18762216
[TBL] [Abstract][Full Text] [Related]
18. Increased blood-brain barrier permeability is not a primary determinant for lethality of West Nile virus infection in rodents.
Morrey JD; Olsen AL; Siddharthan V; Motter NE; Wang H; Taro BS; Chen D; Ruffner D; Hall JO
J Gen Virol; 2008 Feb; 89(Pt 2):467-473. PubMed ID: 18198377
[TBL] [Abstract][Full Text] [Related]
19. Persistent infection and associated nucleotide changes of West Nile virus serially passaged in hamsters.
Wu X; Lu L; Guzman H; Tesh RB; Xiao SY
J Gen Virol; 2008 Dec; 89(Pt 12):3073-3079. PubMed ID: 19008395
[TBL] [Abstract][Full Text] [Related]
20. Viral RNA-Dependent RNA Polymerase Inhibitor 7-Deaza-2'-
Eyer L; Fojtíková M; Nencka R; Rudolf I; Hubálek Z; Ruzek D
Antimicrob Agents Chemother; 2019 Mar; 63(3):. PubMed ID: 30642926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
